AndrewBaschnagelMD

Assistant Professor

Dr. Baschnagel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Corewell Health East Beaumont (Royal Oak)Residency, Radiation Oncology, 2010 - 2014
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 2009 - 2010
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2009

PubMed

Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer.
Rachel L Minne, Natalie Y Luo, Caroline M Mork, Madalynn R Wopat, Karla Esbona
Molecular Pharmaceutics. 2024-12-02
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
Christine M Bestvina, Jared H L Hara, Theodore Karrison, Benjamen Bowar, Janet Chin
Clinical Lung Cancer. 2024-12-01
GABA(A) Receptor Activation Drives GABARAP-Nix Mediated Autophagy to Radiation-Sensitize Primary and Brain-Metastatic Lung Adenocarcinoma Tumors.
Debanjan Bhattacharya, Riccardo Barrile, Donatien Kamdem Toukam, Vaibhavkumar S Gawali, Laura Kallay
Cancers. 2024-09-15

Wisconsin Researchers Well-Represented at International Radiation Oncology ConferenceOctober 22nd, 2018
SPORE Announces $400,000 in Pilot Grants for Head and Neck CancerSeptember 22nd, 2017
Andrew Baschnagel Wins UW Carbone Award for Lung Cancer StudyJuly 25th, 2017